0001437749-23-011378.txt : 20230427
0001437749-23-011378.hdr.sgml : 20230427
20230427163021
ACCESSION NUMBER: 0001437749-23-011378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230425
FILED AS OF DATE: 20230427
DATE AS OF CHANGE: 20230427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Narayan Prabhu
CENTRAL INDEX KEY: 0001829831
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38634
FILM NUMBER: 23857561
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD. SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER NAME:
FORMER CONFORMED NAME: Parbhu Narayan
DATE OF NAME CHANGE: 20201023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001742927
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 4085018881
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: Tenzing Acquisition Corp.
DATE OF NAME CHANGE: 20180606
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-04-25
0001742927
REVIVA PHARMACEUTICALS HOLDINGS, INC.
RVPH
0001829831
Narayan Prabhu
C/O REVIVA PHARMACEUTICALS HOLDINGS, INC
19925 STEVENS CREEK BLVD, SUITE 100
CUPERTINO
CA
95014
1
Chief Financial Officer
0
Stock Option (right to buy)
6.74
2023-04-25
4
A
0
170000
0
A
2033-04-24
Common Stock, par value $0.0001 per share
170000
170000
D
Represents an option award granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the "Reporting Person"), by the Issuer's compensation committee on April 25, 2023 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan.
/s/ Narayan Prabhu
2023-04-27